CANbridge Pharmaceuticals Inc.

  • Market Cap: N/A
  • Industry: Pharmaceuticals & Biotechnology
  • ISIN: KYG1821D1097
HKD
1.99
0.02 (1.02%)
  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationAnnual Results
Results Snapshot
Figures in Million
Consolidated - Balance Sheet Results
Dec'25
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
0.00
0.00
0.00
0.00
0.00
0.00
Share Warrants & Outstandings
Total Reserve
-380.65
-504.96
-43.81
346.43
848.20
-2,069.96
Shareholder's Funds
-380.65
-504.96
-43.81
346.43
848.20
-2,069.96
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
Long-Term Borrowings
17.75
44.83
45.53
56.89
47.40
2,616.23
Secured Loans
17.75
44.83
45.53
56.89
47.40
2,616.23
Unsecured Loans
0.00
0.00
0.00
0.00
0.00
0.00
Deferred Tax Assets / Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Other Long Term Liabilities
48.79
99.66
110.74
117.45
16.33
53.76
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
57.70
115.67
118.03
129.55
16.33
2,637.00
Current Liabilities
Trade Payables
410.81
394.25
218.06
120.74
53.34
55.38
Other Current Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Borrowings
0.00
0.00
0.00
0.00
0.00
0.00
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
507.17
513.60
361.07
312.24
227.26
128.17
Total Liabilities
184.21
124.31
435.30
788.21
1,091.79
695.21
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
13.12
16.30
132.50
173.03
44.15
24.19
Less: Accumulated Depreciation
12.55
12.42
12.49
10.55
8.01
5.73
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
0.57
3.87
120.02
162.48
36.14
18.46
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
0.00
0.00
0.00
Intangible assets under development
0.00
0.00
0.00
0.00
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
0.00
0.00
0.00
3.54
0.00
0.00
Total Non-Current Assets
61.51
76.05
204.23
221.05
98.85
231.57
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
22.91
8.41
9.67
11.03
16.45
0.66
Sundry Debtors
16.84
17.80
34.38
21.39
11.18
8.35
Cash and Bank
74.21
11.18
151.38
519.95
912.33
427.78
Other Current Assets
121.59
46.30
204.55
552.37
962.91
458.09
Short Term Loans and Advances
7.63
8.92
9.12
0.00
22.95
21.30
Total Current Assets
122.71
48.26
231.06
567.16
992.94
463.64
Net Current Assets (Including Current Investments)
-384.46
-465.34
-130.01
254.92
765.68
335.47
Total Current Assets Excluding Current Investments
122.71
48.26
231.06
567.16
992.94
463.64
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
184.21
124.31
435.30
788.21
1,091.79
695.21
Contingent Liabilities
0.00
0.00
0.00
0.00
0.00
0.00
Total Debt
17.75
44.83
45.53
56.89
47.40
2,616.23
Book Value per share (adjusted)
Balance Sheet Analysis Highlights
stock-summary

Compare Balance Sheet Results of CANbridge Pharmaceuticals Inc.
Markets Mojo
Figures in Million
Consolidated - Balance Sheet Results
Markets Mojo
Markets Mojo
Change(HKD)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
0
0
0.00
0.00%
Share Warrants & Outstandings
Total Reserve
-380.65
191.41
-572.06
-298.87%
Shareholder's Funds
-380.65
191.41
-572.06
-298.87%
Minority Interest
0
-35.66
35.66
100.00%
Long-Term Borrowings
17.75
389.24
-371.49
-95.44%
Secured Loans
17.75
389.24
-371.49
-95.44%
Unsecured Loans
0
0
0.00
0.00%
Deferred Tax Assets / Liabilities
0
4.05
-4.05
-100.00%
Other Long Term Liabilities
48.79
58.99
-10.20
-17.29%
Long Term Trade Payables
0
0
0.00
0.00%
Long Term Provisions
0
0
0.00
0.00%
Total Non-Current Liabilities
57.70
201.07
-143.37
-71.30%
Current Liabilities
Trade Payables
410.81
33.70
377.11
1,119.02%
Other Current Liabilities
0
0
0.00
0.00%
Short Term Borrowings
0
0
0.00
0.00%
Short Term Provisions
0
0
0.00
0.00%
Total Current Liabilities
507.17
345.76
161.41
46.68%
Total Liabilities
184.21
702.58
-518.37
-73.78%
ASSETS
Non-Current Assets
0
0
0.00
0.00%
Gross Block
13.12
492.56
-479.44
-97.34%
Less: Accumulated Depreciation
12.55
90.61
-78.06
-86.15%
Less : Impairment of Assets
0
0
0.00
0.00%
Net Block
0.57
401.94
-401.37
-99.86%
Lease Adjustment
0
0
0.00
0.00%
Capital Work in Progress
0
0
0.00
0.00%
Intangible assets under development
0
0
0.00
0.00%
Pre-operative Expenses pending
0
0
0.00
0.00%
Assets in transit
0
0
0.00
0.00%
Non Current Investments
0
30.66
-30.66
-100.00%
Long Term Loans & Advances
0
0
0.00
0.00%
Other Non Current Assets
0
0
0.00
0.00%
Total Non-Current Assets
61.51
622.89
-561.38
-90.13%
Current Assets Loans & Advances
Current Investments
0
0
0.00
0.00%
Inventories
22.91
36.94
-14.03
-37.98%
Sundry Debtors
16.84
5.62
11.22
199.64%
Cash and Bank
74.21
12.08
62.13
514.32%
Other Current Assets
121.59
68.94
52.65
76.37%
Short Term Loans and Advances
7.63
14.30
-6.67
-46.64%
Total Current Assets
122.71
79.69
43.02
53.98%
Net Current Assets (Including Current Investments)
-384.46
-266.07
-118.39
-44.50%
Total Current Assets Excluding Current Investments
122.71
79.69
43.02
53.98%
Miscellaneous Expenses not written off
0
0
0.00
0.00%
Total Assets
184.21
702.58
-518.37
-73.78%
Contingent Liabilities
0
0
0.00
0.00%
Total Debt
17.75
389.24
-371.49
-95.44%
Book Value per share (adjusted)
0
0
0.00
0.00%
Annual - Borrowings
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Other Long Term Liabilities
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Fixed Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Investments
Markets Mojo
Analysis not available as Data has been published for only 1 period
Annual - Current Assets
Markets Mojo
Analysis not available as Data has been published for only 1 period